Space Required
500 Sq.ft

BRAND:
DELWICH
Investment Required:
MODE
Looking for distributors
Investment Required
GST No.
24AAXXXXXXXX
PAN No.
AAUFXXXXXXXX
Established
-
Space Required
500 Sq.ft
No. of Distributors
-
Company Outlets
-
Dellwich Lifescience LLP is an emerging pharmaceutical company committed to providing high-quality and affordable healthcare solutions. Driven by a vision to support better treatment outcomes, the company follows ethical practices, strict quality standards, and a customer-focused approach. With a professional team and a growing presence, Dellwich Lifescience LLP continues to strengthen its position in the competitive pharmaceutical industry.
The company markets its products under the trusted brand Delwich, offering a carefully selected range of formulations across key therapeutic areas. Our product portfolio includes AZICAT-250/500 Tablet, ASCUTE-PS Tablet, CALOCIN 500 Tablet, CEFUDEL-250/500 Tablet, and DELAMOX-CV Tablet 625, among others. Each product is manufactured in compliance with quality norms to ensure consistency, reliability, and acceptance among healthcare professionals.
Dellwich Lifescience LLP is actively expanding its distribution network and invites dedicated distributors and marketing partners to collaborate with us. We offer quality products, promotional support, and long-term growth opportunities. Partner with Delwich to build a successful and sustainable pharmaceutical business together.
Requirements to Become Distributors
Adequate storage space, valid drug license, and sufficient working capital for smooth operations.
Commitment to ethical marketing practices and strong relationships with doctors and retailers.
Ability to maintain inventory, timely payments, and efficient distribution within the assigned territory.
Dedicated team and willingness to grow the brand with long-term business vision.
Benefits the Distributors Will Get
High-quality products with consistent demand and strong acceptance among healthcare professionals.
Attractive profit margins, promotional support, and regular business growth opportunities.
Monopoly rights in the assigned area ensuring focused market development.
Reliable supply chain support and transparent business policies for long-term partnership.
Product Portfolio
AZICAT- 250/500 Tablet
ASCUTE-PS TABLET
CALOCIN 500 Tablet
CEFUDEL 250/500 Tablet
DELAMOX-CVTABLET 625
Features of the Products
Broad-spectrum antibacterial action against commonly encountered bacterial infections.
Formulated with proven, widely prescribed antibiotic molecules trusted by clinicians.
Manufactured under strict quality standards ensuring consistent safety and efficacy.
Generally well tolerated, supporting better patient compliance during therapy.
Available in commonly prescribed strengths for convenient and flexible dosing.
Supports effective infection management when used as prescribed by healthcare professionals.
Strengths of the Company
Wide product range under a trusted brand meeting diverse therapeutic requirement.
Strict quality standards ensuring product safety, consistency, and market credibility.
Professional management, ethical practices, and distributor-focused business approach.
Growing market presence with commitment to sustainable and mutually beneficial growth.
Neuro Product, General Product and Derma Product
Investment Required
City Level
East
West Bengal,
Arunachal Pradesh,
Assam,
Manipur,
Meghalaya,
Mizoram,
Nagaland,
Sikkim,
Tripura,
Odisha,
Union Territories
Andaman and Nicobar Islands,
Chandigarh,
Dadra and Nagar Haveli,
Daman and Diu,
Lakshadweep,
Puducherry,
Dadra and Nagar Haveli and Daman and Diu,
South
Andhra Pradesh,
Karnataka,
Kerala,
Tamil Nadu,
Telangana,
Central
Bihar,
Chhattisgarh,
Jharkhand,
Madhya Pradesh,
North
Delhi,
Haryana,
Himachal Pradesh,
Jammu and Kashmir,
Uttar Pradesh,
Punjab,
Uttarakhand,
West
Goa,
Gujarat,
Maharashtra,
Rajasthan,